Acrivon Therapeutics, Inc. — All Filings
291 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| ARS | ARS | 0000950170-24-048675 | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | DEFA14A | 0000950170-24-048673 | Apr 26, 2024 | — |
| DEF 14A | DEF 14A | 0000950170-24-048671 | Apr 26, 2024 | Jun 20, 2024 |
| CORRESP | — | 0001193125-24-110404 | Apr 24, 2024 | — |
| 8-K | 8-K | 0000950170-24-047560 | Apr 24, 2024 | — |
| 4 | — | 0000905148-24-001186 | Apr 19, 2024 | Apr 17, 2024 |
| UPLOAD | — | 0000000000-24-004299 | Apr 19, 2024 | — |
| S-3 | S-3 | 0001193125-24-099152 | Apr 17, 2024 | — |
| 4 | — | 0001415889-24-010809 | Apr 15, 2024 | Apr 11, 2024 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-008378 | Apr 15, 2024 | Apr 11, 2024 |
| SC 13G/A | SC 13G/A | 0001193125-24-095564 | Apr 15, 2024 | — |
| SC 13D/A | SC 13D/A | 0001104659-24-046306 | Apr 11, 2024 | — |
| 8-K | 8-K | 0000950170-24-042789 | Apr 9, 2024 | Apr 8, 2024 |
| S-8 | S-8 | 0001193125-24-081596 | Mar 29, 2024 | — |
| 8-K | 8-K | 0000950170-24-037627 | Mar 28, 2024 | — |
| 10-K | 10-K | 0000950170-24-037618 | Mar 28, 2024 | Dec 31, 2023 |
| 4 | — | 0000905148-24-000904 | Mar 6, 2024 | Mar 4, 2024 |
| 3 | — | 0000905148-24-000901 | Mar 6, 2024 | Mar 4, 2024 |
| 8-K | 8-K | 0001193125-24-056937 | Mar 4, 2024 | — |
| 4 | — | 0000905148-24-000765 | Feb 16, 2024 | Feb 14, 2024 |
| 4 | — | 0000905148-24-000764 | Feb 16, 2024 | Feb 14, 2024 |
| 4 | — | 0000905148-24-000763 | Feb 16, 2024 | Feb 14, 2024 |
| 4 | — | 0000905148-24-000762 | Feb 16, 2024 | Feb 14, 2024 |
| 4 | — | 0000905148-24-000761 | Feb 16, 2024 | Feb 14, 2024 |
| 4 | — | 0000905148-24-000760 | Feb 16, 2024 | Feb 14, 2024 |
| SC 13G/A | SC 13G/A | 0001104659-24-023918 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-036370 | Feb 14, 2024 | — |
| SC 13G/A | ACRIVON THERAPEUTICS, INC. | 0000902664-24-001626 | Feb 14, 2024 | — |
| SC 13G/A | — | 0000908834-24-000055 | Feb 13, 2024 | — |
| 4 | — | 0000905148-24-000533 | Feb 9, 2024 | Feb 8, 2024 |
| 3 | — | 0000905148-24-000531 | Feb 9, 2024 | Feb 8, 2024 |
| 8-K | 8-K | 0001193125-24-027629 | Feb 8, 2024 | Feb 7, 2024 |
| 4 | — | 0000905148-24-000240 | Jan 19, 2024 | Jan 17, 2024 |
| 4 | — | 0000905148-24-000183 | Jan 16, 2024 | Jan 11, 2024 |
| 3 | — | 0000905148-24-000165 | Jan 12, 2024 | Jan 2, 2024 |
| 8-K | 8-K | 0001193125-24-003885 | Jan 8, 2024 | — |
| EFFECT | — | 9999999995-23-003657 | Dec 15, 2023 | — |
| CORRESP | — | 0001193125-23-293526 | Dec 12, 2023 | — |
| 8-K | 8-K | 0001193125-23-291705 | Dec 8, 2023 | Dec 4, 2023 |
| UPLOAD | — | 0000000000-23-013218 | Dec 5, 2023 | — |
| S-3 | S-3 | 0001193125-23-287501 | Dec 1, 2023 | — |
| 4 | — | 0000905148-23-001477 | Nov 16, 2023 | Nov 14, 2023 |
| 4 | — | 0000905148-23-001476 | Nov 16, 2023 | Nov 14, 2023 |
| 4 | — | 0000905148-23-001475 | Nov 16, 2023 | Nov 14, 2023 |
| 4 | — | 0000905148-23-001474 | Nov 16, 2023 | Nov 14, 2023 |
| 4 | — | 0000905148-23-001473 | Nov 16, 2023 | Nov 14, 2023 |
| 4 | — | 0000905148-23-001472 | Nov 16, 2023 | Nov 14, 2023 |
| 8-K | 8-K | 0001193125-23-274124 | Nov 9, 2023 | — |
| 10-Q | 10-Q | 0000950170-23-061553 | Nov 9, 2023 | Sep 30, 2023 |
| 4 | — | 0000905148-23-001156 | Oct 19, 2023 | Oct 17, 2023 |